Project Grant HT94252410182
Award Date
4/1/24
Completion Date
3/31/28
Dollars Obligated
$6.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
The University of California, San Francisco (UCSF) has been awarded a $726,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year federal grant, with a period of performance from June 2024 to June 2027, will support research to elucidate the role of ERα RNA binding activity in breast cancer progression and drug-tolerant persister cells. As a leading academic medical center with extensive experience in federally...
The Regents of the University of California, San Francisco will receive $4.8 million over four years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to reveal and target multiple pathways of breast cancer metastasis, with the goal of transforming healthcare for service members and the public through innovative biomedical research focused on investigating medical...
The University of California, San Francisco will receive $3.23 million over four years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research combining immunotherapy and synthetic lethality targeting for metastatic breast cancer. Through this award made on September 15, 2021, the University aims to investigate medical solutions for metastatic breast cancer on the battlefield and...
The Regents of the University of California, San Francisco will receive $565,250 from the Department of the Army Medical Command through May 2025 under a Project Grant award from the Military Medical Research and Development program (CFDA 12.420).
The grant will fund research investigating mutation burden in normal skin as a predictor of melanoma risk. Specifically, the University of California, San Francisco will conduct basic, applied, and advanced biomedical research to transform military...
This $807,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Regents of the University of California, San Francisco (UCSF) in targeting the PIM kinase pathway to eliminate breast cancer metastasis. The project will be conducted from July 1, 2023 to June 30, 2025. UCSF is a prime grantee with relevant expertise in biomedical research and healthcare services, having previously contracted with federal agencies...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
The Department of the Army Medical Command awarded a $5.3 million cooperative agreement to the Regents of the University of California, San Francisco for the period of August 1, 2022 through July 31, 2026. The award will support the University's efforts to prevent lethal metastatic breast cancer through the identification and eradication of clinically relevant disseminated tumor cells.
This cooperative agreement was awarded under the Military Medical Research and Development program (CFDA...
The Department of the Army Medical Command awarded a $161,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Deciphering Translational Control of Androgen Receptor in Prostate Cancer". The grant project will run from April 1, 2024 to March 31, 2026. As a leading academic medical center and research institution, UCSF has extensive expertise in federal...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,228,594.00 to the Regents of the University of California, San Francisco (UCSF) for research on bispecific antibody-drug conjugates against emerging targets in metastatic lethal prostate cancer. The award period is from April 15, 2024 to April 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...